135 related articles for article (PubMed ID: 37532537)
1. Continuous Monitoring of the Agglomeration and Sedimentation of Indomethacin Nanosuspensions Using T
Ono T; Okada K; Tsuchiya M; Hayashi Y; Kumada S; Onuki Y
Chem Pharm Bull (Tokyo); 2023; 71(8):665-669. PubMed ID: 37532537
[TBL] [Abstract][Full Text] [Related]
2. Nondestructive Investigation of the Agglomeration Process for Nanosuspensions via NMR Relaxation of Water Molecules.
Okada K; Hayashi Y; Kumada S; Onuki Y
Eur J Pharm Sci; 2021 Sep; 164():105908. PubMed ID: 34118410
[TBL] [Abstract][Full Text] [Related]
3. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
4. T
Okada K; Hirai D; Hayashi Y; Kumada S; Kosugi A; Onuki Y
Chem Pharm Bull (Tokyo); 2019; 67(6):580-586. PubMed ID: 31155564
[TBL] [Abstract][Full Text] [Related]
5. Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution.
He W; Lu Y; Qi J; Chen L; Yin L; Wu W
Int J Nanomedicine; 2013; 8():3119-28. PubMed ID: 23983465
[TBL] [Abstract][Full Text] [Related]
6. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
7. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
Karakucuk A; Celebi N
Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
[TBL] [Abstract][Full Text] [Related]
9. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.
Van Eerdenbrugh B; Froyen L; Van Humbeeck J; Martens JA; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):127-35. PubMed ID: 18644441
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of drug-loaded edible carrier substrates from nanosuspensions by flexographic printing.
Palo M; Kolakovic R; Laaksonen T; Määttänen A; Genina N; Salonen J; Peltonen J; Sandler N
Int J Pharm; 2015 Oct; 494(2):603-610. PubMed ID: 25601198
[TBL] [Abstract][Full Text] [Related]
11. Is roller milling - the low energy wet bead media milling - a reproducible and robust milling method for formulation investigation of aqueous suspensions?
Zulbeari N; Holm R
Int J Pharm; 2024 Feb; 651():123733. PubMed ID: 38142873
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.
Singhal M; Baumgartner A; Turunen E; van Veen B; Hirvonen J; Peltonen L
Int J Pharm; 2020 Sep; 587():119636. PubMed ID: 32659405
[TBL] [Abstract][Full Text] [Related]
14. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
15. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
[TBL] [Abstract][Full Text] [Related]
16. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
[TBL] [Abstract][Full Text] [Related]
17. Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads.
Kayaert P; Anné M; Van den Mooter G
J Pharm Pharmacol; 2011 Nov; 63(11):1446-53. PubMed ID: 21988425
[TBL] [Abstract][Full Text] [Related]
18. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
19. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.
He W; Lu Y; Qi J; Chen L; Hu F; Wu W
Int J Pharm; 2013 Jan; 441(1-2):269-78. PubMed ID: 23194889
[TBL] [Abstract][Full Text] [Related]
20. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
